Search Results
Search for other papers by Catarina I Gonçalves in
Google Scholar
PubMed
Search for other papers by José M Aragüés in
Google Scholar
PubMed
Search for other papers by Margarida Bastos in
Google Scholar
PubMed
Search for other papers by Luísa Barros in
Google Scholar
PubMed
Search for other papers by Nuno Vicente in
Google Scholar
PubMed
Search for other papers by Davide Carvalho in
Google Scholar
PubMed
Search for other papers by Manuel C Lemos in
Google Scholar
PubMed
Introduction Congenital hypogonadotropic hypogonadism (CHH) is characterised by partial or complete lack of pubertal development, secondary to deficient gonadotropin-releasing hormone (GnRH)-induced gonadotropin secretion ( 1 ). Diagnosis is
Search for other papers by Mei Li in
Google Scholar
PubMed
Search for other papers by Yanfei Chen in
Google Scholar
PubMed
Search for other papers by Binrong Liao in
Google Scholar
PubMed
Search for other papers by Jing Tang in
Google Scholar
PubMed
Search for other papers by Jingzi Zhong in
Google Scholar
PubMed
Search for other papers by Dan Lan in
Google Scholar
PubMed
Introduction In humans, the initiation of puberty is caused by reactivation of the hypothalamic-pituitary-gonadal (HPG) axis with re-emergence of pulsatile hypothalamic gonadotropin-releasing hormone (GnRH) secretion, leading to the release of
Search for other papers by Chan Sub Park in
Google Scholar
PubMed
Search for other papers by Jihye Choi in
Google Scholar
PubMed
Search for other papers by Min-Ki Seong in
Google Scholar
PubMed
Search for other papers by Sung-Eun Hong in
Google Scholar
PubMed
Search for other papers by Jae-Sung Kim in
Google Scholar
PubMed
Search for other papers by In-Chul Park in
Google Scholar
PubMed
Search for other papers by Hyesil Seol in
Google Scholar
PubMed
Search for other papers by Woo Chul Noh in
Google Scholar
PubMed
Search for other papers by Hyun-Ah Kim in
Google Scholar
PubMed
in patients with pS6K1-positive than -negative tumors. Estrogen depletion therapy was developed for treating HR-positive breast cancer in recent decades. Gonadotropin-releasing hormone (GnRH) agonists are specific estradiol depletion therapy for
Search for other papers by Luminita Nicoleta Cima in
Google Scholar
PubMed
Hematology Department, Fundeni Hospital, Bucharest, Romania
Search for other papers by Anca Colita in
Google Scholar
PubMed
Endocrine Department, Elias Hospital, Bucharest, Romania
Search for other papers by Simona Fica in
Google Scholar
PubMed
review from reliable electronic databases conducted between October 2016 and April 2017 using the following key words related to the topic: ‘gonadotropin-releasing hormone analogues’, ‘GnRHa’, ‘luteinizing hormone-releasing hormone agonist’, ‘LHRHa
Search for other papers by Rajae Talbi in
Google Scholar
PubMed
Search for other papers by Victor M Navarro in
Google Scholar
PubMed
–pituitary–gonadal (HPG) axis. Within the HPG axis, reproductive function is regulated by gonadotropin-releasing hormone (GnRH) neurons located in the hypothalamus, which control the production and release of gonadotropins from the pituitary to regulate gonadal function
Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, University Regional Hospital of Patras, Rio, Greece
Mount Auburn Hospital, Harvard Medical School Teaching Hospital, Cambridge, Massachusetts, USA
Search for other papers by M I Stamou in
Google Scholar
PubMed
Search for other papers by P Varnavas in
Google Scholar
PubMed
Search for other papers by L Plummer in
Google Scholar
PubMed
Search for other papers by V Koika in
Google Scholar
PubMed
Search for other papers by N A Georgopoulos in
Google Scholar
PubMed
Introduction Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is a rare disease with a wide spectrum of reproductive and non-reproductive clinical characteristics. Apart from the phenotypic heterogeneity, IGD is also a
Search for other papers by Rui-yi Tang in
Google Scholar
PubMed
Search for other papers by Rong Chen in
Google Scholar
PubMed
Search for other papers by Miao Ma in
Google Scholar
PubMed
Search for other papers by Shou-qing Lin in
Google Scholar
PubMed
Search for other papers by Yi-wen Zhang in
Google Scholar
PubMed
Search for other papers by Ya-ping Wang in
Google Scholar
PubMed
seeking to conceive, 1 patient unsuccessfully underwent pulsatile gonadotropin-releasing hormone (GnRH) treatment. Ten patients underwent ovulation induction with gonadotropin, including 4 women who became pregnant and 2 women who failed and gave up
Search for other papers by Eleftherios E Deiktakis in
Google Scholar
PubMed
Search for other papers by Eleftheria Ieronymaki in
Google Scholar
PubMed
Search for other papers by Peter Zarén in
Google Scholar
PubMed
Search for other papers by Agnes Hagsund in
Google Scholar
PubMed
Search for other papers by Elin Wirestrand in
Google Scholar
PubMed
Search for other papers by Johan Malm in
Google Scholar
PubMed
Search for other papers by Christos Tsatsanis in
Google Scholar
PubMed
Imperial College London, Institute of Reproductive and Developmental Biology, London, UK
Search for other papers by Ilpo T Huhtaniemi in
Google Scholar
PubMed
Malmö University Hospital, Reproductive Medicine Center, Malmö, Sweden
Search for other papers by Aleksander Giwercman in
Google Scholar
PubMed
Search for other papers by Yvonne Lundberg Giwercman in
Google Scholar
PubMed
Introduction For decades, gonadotropin-releasing hormone (GnRH) agonists have formed the mainstay hormonal treatment of prostate cancer ( 1 ). While they generate suppression of testosterone due to persistent suppression of luteinizing hormone
Search for other papers by Shota Dzemaili in
Google Scholar
PubMed
Search for other papers by Jitske Tiemensma in
Google Scholar
PubMed
Search for other papers by Richard Quinton in
Google Scholar
PubMed
Search for other papers by Nelly Pitteloud in
Google Scholar
PubMed
Faculty of Nursing Science, Laval University, Québec City, Canada
Search for other papers by Diane Morin in
Google Scholar
PubMed
Endocrinology, Diabetes & Metabolism Service of the Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Search for other papers by Andrew A Dwyer in
Google Scholar
PubMed
Introduction Infertility affects ~10–15% of women globally and is a significant health concern ( 1 ). Sometimes referred to as the pilot light of reproduction, gonadotropin-releasing hormone (GnRH) secretion is essential for developing and
Search for other papers by Imane Benabbad in
Google Scholar
PubMed
Search for other papers by Myriam Rosilio in
Google Scholar
PubMed
Search for other papers by Maité Tauber in
Google Scholar
PubMed
Search for other papers by Emmanuel Paris in
Google Scholar
PubMed
Search for other papers by Anne Paulsen in
Google Scholar
PubMed
Search for other papers by Lovisa Berggren in
Google Scholar
PubMed
Search for other papers by Hiren Patel in
Google Scholar
PubMed
Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Universitaire Robert-Debré, Department of Pediatric Endocrinology and Diabetology, and Centre de Référence des Maladies Endocriniennes Rares de la Croissance, Paris, France
Search for other papers by Jean-Claude Carel in
Google Scholar
PubMed
Search for other papers by the Phoenix Study Group in
Google Scholar
PubMed
348 908 – 917 . ( https://doi.org/10.1056/NEJMoa013555 ) 10.1056/NEJMoa013555 13 Dunkel L. Treatment of idiopathic short stature: effects of gonadotropin-releasing hormone analogs, aromatase inhibitors and anabolic steroids . Hormone Research